  See all
 |
Articles: Clinical Pharmacology |
Prior Articles
Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention
Seminars in Arthritis and Rheumatism, 07/07/09
Chondroitin sulphate: an effective joint lubricant
Osteoarthritis and Cartilage, 07/07/09 Emergence of Crohn's Disease During Treatment with the Anti-Tumor Necrosis Factor Agent Etanercept for Ankylosing Spondylitis: Possible Mechanisms of Action
Seminars in Arthritis and Rheumatism, 07/07/09 Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate
Arthritis Care and Research, 07/06/09
Exclusive Author Commentary Prospective evaluation of a shortened regimen of treatment for acute osteomyelitis and septic arthritis in children
Journal of Pediatric Orthopaedics, 07/06/09 Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab
Arthritis Research & Therapy, 07/06/09
Free full text
Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management
Mayo Clinic Proceedings, 07/06/09 Treatment with Infliximab plus Methotrexate Improves Anemia in Patients with Rheumatoid Arthritis Independent of Improvement in Other Clinical Outcome Measures
Seminars in Arthritis and Rheumatism, 07/06/09 Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate
Rheumatology, 07/06/09 The Potential of Liposomal Drug Delivery for the Treatment of Inflammatory Arthritis
Seminars in Arthritis and Rheumatism, 07/06/09 Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: A pilot implementation study
Journal of Rheumatology, 07/02/09 Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis
Journal of Rheumatology, 07/02/09 E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy
Journal of Rheumatology, 07/02/09 Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
Therapeutics and Clinical Risk Management, 07/02/09
Free full text
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor-alpha inhibitors (GO-AFTER study): A multicentre, randomised, double-blind, placebo-controlled, phase III trial
The Lancet - Early Online Publication, 07/01/09 Predicting the future of anti-TNF therapy
Arthritis Research & Therapy, 07/01/09
Free full text
Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia
Seminars in Arthritis and Rheumatism, 07/01/09 Newer therapies for vasculitis
Best Practice & Research: Clinical Rheumatology, 07/01/09 Sarcoidosis Appearing During Anti-Tumor Necrosis Factor alpha Therapy: A New “Class Effect” Paradoxical Phenomenon. Two Case Reports and Literature Review
Seminars in Arthritis and Rheumatism, 07/01/09 Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: An observational study
Clinical Reviews in Allergy and Immunology, 06/30/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology
more...
|
250 Available Pages
|
|
